Leaderboards/brain metastases and treatment

brain metastases and treatment

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Georgina V. Long
The University of Sydney
99
2
Luis Paz‐Ares
Universidad Complutense de Madrid
90
3
Benjamin Izar
Columbia University Irving Medical Center
80
4
Helen Rizos
The University of Sydney
70
5
Enriqueta Felip
Hebron University
60
6
Dihua Yu
The University of Texas MD Anderson Cancer Center
30
7
Afshin Dowlati
University Hospitals Seidman Cancer Center
20

Rising Stars Papers

1
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
Nature Medicine|2025
55 cit.
2
Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition
Nature Cell Biology|2024
50 cit.
3
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens
Nature Biotechnology|2024
34 cit.
4
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors
EBioMedicine|2024
6 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Pasi A. Jänne
Dana-Farber Cancer Institute
99
2
Ernest Nadal
Institut d'Investigació Biomédica de Bellvitge
90
3
Charles M. Rudin
Memorial Sloan Kettering Cancer Center
80
4
Andrea Boutros
Ospedale Policlinico San Martino
70
5
Chibawanye Ene
The University of Texas MD Anderson Cancer Center
60
6
S.-H. Lee
Samsung Medical Center
50
7
Arseniy E. Yuzhalin
The University of Texas MD Anderson Cancer Center
40
8
Katrina Evans
University of California, Irvine
30
9
Spencer S. Watson
University Hospital of Lausanne
20
10
Sara A. Hurvitz
Fred Hutch Cancer Center
10

Emerging Leaders Papers

1
Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial
Journal of Clinical Oncology|2023
279 cit.
2
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
The Lancet Oncology|2024
148 cit.
3
Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis
Nature Cell Biology|2023
52 cit.
4
Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition
Nature Cell Biology|2024
50 cit.
5
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
Science Translational Medicine|2023
44 cit.
6
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
Journal of Thoracic Oncology|2022
35 cit.
7
SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing
Journal of Hematology & Oncology|2024
32 cit.
8
FOXA2 promotes metastatic competence in small cell lung cancer
Nature Communications|2025
9 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Gén Kobashi
Hokkaido University
99
2
Byron Young
Lexington VA Health Care System
90
3
Nancy Farnan
RTOG Foundation
80
4
Andrew Bottomley
Technion – Israel Institute of Technology
70
5
Minesh P. Mehta
University of Wisconsin–Madison
60
6
Naoki Niikura
Tokai University
50
7
Elaine M. Rankin
National Health Service
50
8
E Alexander
Brigham and Women's Hospital
40
9
Priscilla K. Brastianos
Harvard University
40
10
Jay S. Loeffler
Brigham and Women's Hospital
30

All-Time Leaders Papers

1
Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases
Neuro-Oncology|2019
99 cit.
2
5-Azacitidine Partially Resets the Subcellular Localization of YAP in Human Bone Marrow-Derived Mesenchymal Stem Cells
Cells|2026
0 cit.

Reagents for brain metastases and treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

COL3A1 Antibody

Cited in 5 papers
#30565$317
View Evidence →Cell Signaling Technology

Phospho-PLCbeta3 (Ser537) Antibody

#2481$362
View Evidence →Cell Signaling Technology

Mouse (MOPC-21) Monoclonal Antibody IgG1 Isotype Control (Alexa Fluor® 647 Conjugate)

#4843$155
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

LshCas13a/C2c2 (Leptotrichia shahii) (7D1-H7) Mouse Monoclonal Antibody

Cited in 17 papers
#43731$158
View Evidence →Cell Signaling Technology

Stat5 (3H7) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 7 papers
#57580$865
View Evidence →Cell Signaling Technology

CD97 (F1B5E) Rabbit Monoclonal Antibody

Cited in 6 papers
#42684$178
View Evidence →